Clinically Meaningful Tumor Reduction Rates Vary by Prechemotherapy MRI Phenotype and Tumor Subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

PURPOSE: This study was designed to determine (1) rates of clinically meaningful tumor reduction in breast tumor size following neoadjuvant chemotherapy (NAC), (2) which receptor subtypes and MRI phenotypes are associated with clinically meaningful tumor reduction, and (3) whether MRI phenotype impa...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Mukhtar, Rita A., Yau, Christina, Rosen, Mark, Tandon, Vickram J., Hylton, Nola, Esserman, Laura J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer US 2013
Soggetti:
Breast Oncology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3824937/
https://ncbi.nlm.nih.gov/pubmed/23780381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-013-3038-y
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi